| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |